Cataract

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
6 Unique IMPs
1 Commercial trials
Drug classes (ATC)
S Ophthalmology/ENT (ATC S) 1
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 2 substances
Unknown / small molecule 2 substances
Macrolide / aminoglycoside 1 substance
Benzodiazepine 1 substance
Phase III: 1 Phase III/IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Medivis S.r.l. Commercial
    DEXAMETHASONE PHOSPHATE; DEXAMETHASONE SODIUM PHOSPHATE, NEPAFENAC; NEPAFENAC; TOBRAMYCIN
    2025-523367-38-00 1 country 2026 n=432
    Recruiting

Phase III/IV

1 trial
  • Medical University Of Graz Academic
    BROMAZEPAM; LUPULI FLOS DRY ALCOHOLIC EXTRACT, VALERIAN ROOT TE WITH ETHANOL/ETHANOL WATER, TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V)
    2024-520132-15-00 1 country 2025 n=240
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Medivis S.r.l. Commercial 1 Phase III 1
Medical University Of Graz Academic 1 Phase III/IV 1
New trials by year
2025
1
2026
1
← All indication landscapes